Adverse Cutaneous Drug Reactions Collection of Clinical Data and Biological Samples
Objective: To collect clinical data and cutaneous and biological samples for immunological, biological and genetic studies to improve knowledge about pathophysiology of drug reactions. Method: The following samples will be performed in addition to the routine practice samples: one skin punch biopsy (6mm); 43 mL of blood; blister fluid aspiration; oral and nose mucous membrane and skin eSWABs, stool samples. These samples will be stored in a dedicated biological sampling department (Platform of biological resources).
Conclusion: The implementation of this collection should allow us to conduct pathophysiological studies about drug reactions.
• Patient ≥ 18 y-old
• Severe cutaneous drug reaction (AGEP, DRESS, SJS/TEN, generalized bullous fixed drug eruption), drug-induced IgA bullous dermatosis, maculopapular exanthema, erythema multiforme
• Signed consent
• Social security affiliation